These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7970145)

  • 21. Inhibition of rat corticotropin-releasing factor and adrenocorticotropin secretion by an osmotic stimulus.
    Jessop DS; Chowdrey HS; Lightman SL
    Brain Res; 1990 Jul; 523(1):1-4. PubMed ID: 2169961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of centrally administered neuropeptide Y on hypothalamic and hypophyseal proopiomelanocortin-derived peptides in the rat.
    Blasquez C; Jégou S; Friard O; Tonon MC; Fournier A; Vaudry H
    Neuroscience; 1995 Sep; 68(1):221-7. PubMed ID: 7477927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACTH content in the anterior pituitary after the infusion of various doses of corticosterone and dexamethasone in normal and adrenalectomized rats.
    Sakakura M; Yoshioka M; Kobayashi M
    Tohoku J Exp Med; 1982 Jun; 137(2):191-8. PubMed ID: 6287667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-endorphin inhibits hypoglycemia-induced gene expression of corticotropin-releasing factor in the rat hypothalamus.
    Suda T; Sato Y; Sumitomo T; Nakano Y; Tozawa F; Iwai I; Yamada M; Demura H
    Endocrinology; 1992 Mar; 130(3):1325-30. PubMed ID: 1311237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus.
    Sumitomo T; Suda T; Nakano Y; Tozawa F; Yamada M; Demura H
    Endocrinology; 1991 May; 128(5):2248-52. PubMed ID: 1850346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dexamethasone on immunoreactive corticotropin-releasing factor in the rat median eminence and intermediate-posterior pituitary.
    Suda T; Tomori N; Tozawa F; Mouri T; Demura H; Shizume K
    Endocrinology; 1984 Mar; 114(3):851-4. PubMed ID: 6321142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ACTH release in pituitary cell cultures. Effect of neurogenic peptides and neurotransmitter substances on ACTH release induced by hypothalamic corticotropin releasing factor (CRF).
    Hashimoto K; Yunoki S; Takahara J; Ofuji T
    Endocrinol Jpn; 1979 Feb; 26(1):103-9. PubMed ID: 35343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus.
    Suda T; Yajima F; Tomori N; Demura H; Shizume K
    Life Sci; 1985 Oct; 37(16):1499-505. PubMed ID: 2995748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ
    Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasma ACTH responses to stress in nonhandled compared with handled rats require basal levels of corticosterone and are associated with increased levels of ACTH secretagogues in the median eminence.
    Viau V; Sharma S; Plotsky PM; Meaney MJ
    J Neurosci; 1993 Mar; 13(3):1097-105. PubMed ID: 8382733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of dynamics of corticotropin-releasing factor (CRF) activity in the rat hypothalamus under stress].
    Fujieda K
    Hokkaido Igaku Zasshi; 1976 May; 51(3):199-216. PubMed ID: 184025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in responsiveness of the hypothalamic-pituitary-adrenocortical axis to 2-deoxy-D-glucose in developing rats.
    Widmaier EP
    Endocrinology; 1990 Jun; 126(6):3116-23. PubMed ID: 2161749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor-mediated actions of corticotropin-releasing factor in pituitary gland and nervous system.
    Aguilera G; Wynn PC; Harwood JP; Hauger RL; Millan MA; Grewe C; Catt KJ
    Neuroendocrinology; 1986; 43(1):79-88. PubMed ID: 3012395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
    J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties and regulation of high-affinity pituitary receptors for corticotropin-releasing factor.
    Wynn PC; Aguilera G; Morell J; Catt KJ
    Biochem Biophys Res Commun; 1983 Jan; 110(2):602-8. PubMed ID: 6301458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplantation of the pituitary pars distalis induces the corticotrophs to store melanocyte-stimulating hormone, an effect reversed by the administration of corticotropin-releasing factor.
    Iturriza FC; Ferese-Spinelli CG
    Neuroendocrinology; 1991 Jan; 53(1):75-8. PubMed ID: 1646413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corticotropin-releasing factor (CRF) is involved in the acute anorexic effect of alpha-melanocyte-stimulating hormone: a study using CRF-deficient mice.
    Kawashima S; Sakihara S; Kageyama K; Nigawara T; Suda T
    Peptides; 2008 Dec; 29(12):2169-74. PubMed ID: 18930089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF.
    Bruhn TO; Plotsky PM; Vale WW
    Endocrinology; 1984 Jan; 114(1):57-62. PubMed ID: 6317350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-melanocyte-stimulating hormone inhibits corticotropin-releasing factor release by blocking protein kinase C.
    Lyson K; McCann SM
    Neuroimmunomodulation; 1994; 1(3):153-8. PubMed ID: 7489328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus.
    Suda T; Tozawa F; Iwai I; Sato Y; Sumitomo T; Nakano Y; Yamada M; Demura H
    Brain Res Mol Brain Res; 1993 Jun; 18(4):311-5. PubMed ID: 8392133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.